戻る Agenda
CMIC Holdings Innovation Theater: Make the Impossible Possible - An Innovative Partnership for Market Entry in Japan
Session Chair(s)
CMIC HOLDINGS Co., Ltd.
CMIC Co., Ltd., Japan
CMIC, the leading CRO in Japan, and MEDIPAL, the leading pharma wholesaler joined forces to create OrphanPacific with a mission: accelerate the introduction of innovative medicines to treat rare diseases in Japan. Inspired by the experience of outsourcing, OrphanPacific introduced IPM, Innovative Pharma Model, assisting biotech firms without local operations to introduce their asset in Japan. The partnership with BioCryst provides an exceptional business case demonstrating the value of IPM.
Speaker(s)
Philippe Auvaro
CMIC HOLDINGS Co., Ltd./Orphan Pacific Inc, Japan
OrphanPacific, Inc., President, Representative Director
Megan Sniecinski, MBA
BioCryst Pharmaceuticals, Inc., United States
Chief Business Officer